Both secondary prevention (such as lifestyle modifications, pharmacotherapy or surgery)
and an understanding of the influence of risk factors (including the different aetiologic …

Background: Although aspirin is effective in the secondary prevention of stroke among men
and women, its use in primary prevention remains controversial. We conducted a meta …

Untreated patients who have suffered a transient isch emic attack (TIA) or nondisabling
ischemic stroke have an annual risk of death from all vascular causes, nonfatal stroke, or …

According to meta-analyses aspirin provides a relative reduction in the rate of major
vascular events of 19% in patients with arterial disease in general, whereas for patients with …

Background Aspirin therapy reduces stroke by about 25% for persons with atherosclerotic
vascular disease, but the effect in those without clinically apparent vascular disease is …

OBJECTIVE: To evaluate the efficacy of aspirin for the treatment and prevention of ischemic
stroke and identify the minimum dose proven to be effective for each indication. DATA …

Stroke prevention using antiplatelet agents is now a routine part of therapy in patients with
transient ischaemic attack (TIA) or stroke. Aspirin (acetylsalicylic acid) is the most widely …

Stroke is a leading cause of long-term disability in adults and the fifth leading cause of
mortality in the United States. One of the main tasks related to stroke in the family medicine …

Aspirin is the standard medical therapy for secondary prevention of stroke in patients at risk.
Several randomized, double-blind trials evaluating various antiplatelet agents and a large …

Antiplatelet therapy has become the mainstay of secondary stroke prevention. Recurrence
risk after transient ischemic attack (TIA) or ischemic stroke ranges from 5% to 20% per year …